Cocrystalline DHEA Formulations

Anders L. Berkenstam (Inventor), Edward Kuczynski, (Inventor), S Andersson, Alf (Inventor), Jan-Ake Gustafsson (Inventor), Carly S. Filgueira (Inventor)

Research output: Patent


A cocrystalline DHEA composition with at least one additional coformer is disclosed for therapeutic formulations. The cocrystalline DHEA/coformer formulation including at least one coformer chosen from the group consisting of glutaric acid, maleic acid, tartaric acid, fructose, and wherein the L-isomer of tartaric acid and the D-isomer of fructose are utilized. The cocrystalline DHEA/coformer formulations include certain excipients as a solubilizer or inhibitor.

Original languageEnglish (US)
Patent numberUS2014315833
IPCC07C 49/ 727 A I
Priority date4/21/14
StatePublished - Oct 23 2014


Dive into the research topics of 'Cocrystalline DHEA Formulations'. Together they form a unique fingerprint.

Cite this